These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


817 related items for PubMed ID: 24572675

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [Abstract] [Full Text] [Related]

  • 3. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL, Honavar SG, Shields JA, Demirci H, Meadows AT, Naduvilath TJ.
    Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
    [Abstract] [Full Text] [Related]

  • 4. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.
    Shields CL, Kaliki S, Shah SU, Bianciotto CG, Liu D, Jabbour P, Griffin GC, Shields JA.
    Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
    Berry JL, Bechtold M, Shah S, Zolfaghari E, Reid M, Jubran R, Kim JW.
    Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
    [Abstract] [Full Text] [Related]

  • 7. Practical approach to management of retinoblastoma.
    Shields CL, Mashayekhi A, Demirci H, Meadows AT, Shields JA.
    Arch Ophthalmol; 2004 May; 122(5):729-35. PubMed ID: 15136321
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC, Cicciarelli N, Feuer W, Toledano S, Murray TG.
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [Abstract] [Full Text] [Related]

  • 12. Periocular topotecan for vitreous seeds in retinoblastoma.
    Sthapit PR, Rao R, Honavar SG.
    Indian J Ophthalmol; 2018 Dec; 66(12):1833-1838. PubMed ID: 30451190
    [Abstract] [Full Text] [Related]

  • 13. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA.
    Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
    [Abstract] [Full Text] [Related]

  • 14. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.
    Shields CL, Manjandavida FP, Arepalli S, Kaliki S, Lally SE, Shields JA.
    JAMA Ophthalmol; 2014 Mar; 132(3):319-25. PubMed ID: 24407202
    [Abstract] [Full Text] [Related]

  • 15. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
    Shields CL, Manjandavida FP, Lally SE, Pieretti G, Arepalli SA, Caywood EH, Jabbour P, Shields JA.
    Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
    [Abstract] [Full Text] [Related]

  • 16. Long-term visual outcome following chemoreduction for retinoblastoma.
    Demirci H, Shields CL, Meadows AT, Shields JA.
    Arch Ophthalmol; 2005 Nov; 123(11):1525-30. PubMed ID: 16286614
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chemoreduction for unilateral retinoblastoma.
    Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Naduvilath TJ.
    Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
    [Abstract] [Full Text] [Related]

  • 19. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
    Zage PE, Reitman AJ, Seshadri R, Weinstein JL, Mets MB, Zeid JL, Greenwald MJ, Strauss LC, Goldman S.
    Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
    [Abstract] [Full Text] [Related]

  • 20. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
    Brichard B, De Bruycker JJ, De Potter P, Neven B, Vermylen C, Cornu G.
    Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 41.